Stemline Therapeutics Inc

STML

Sector
Healthcare

Industry
Biotechnology

Website
stemline.com




Buy / Sell (dollars)

1 Month

0% 0% Complete (success)
100% 100% Complete (danger)
$0.00
avg. $0.00
$368,408.59
avg. $368,408.59

Buy/Sell Ratio

0

Transactions

2

Filers

2

3 Month

0% 0% Complete (success)
100% 100% Complete (danger)
$0.00
avg. $0.00
$2.083M
avg. $694,169.72

Buy/Sell Ratio

0

Transactions

14

Filers

3

12 Month

0% 0% Complete (success)
100% 100% Complete (danger)
$0.00
avg. $0.00
$2.906M
avg. $242,199.01

Buy/Sell Ratio

0

Transactions

34

Filers

9

24 Month

0% 0% Complete (success)
100% 100% Complete (danger)
$0.00
avg. $0.00
$5.647M
avg. $235,307.47

Buy/Sell Ratio

0

Transactions

62

Filers

10

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers